ARTERIOVENOUS MALFORMATIONS OF THE BRAIN AND SPINAL CORD

Published on 10/04/2015 by admin

Filed under Neurology

Last modified 10/04/2015

Print this page

rate 1 star rate 2 star rate 3 star rate 4 star rate 5 star
Your rating: none, Average: 3 (1 votes)

This article have been viewed 1889 times

CHAPTER 44 ARTERIOVENOUS MALFORMATIONS OF THE BRAIN AND SPINAL CORD

An arteriovenous malformation (AVM) consists of one or more arteriovenous shunts, which corresponds to an abnormal capillary bed with a shortened arteriovenous transit time. Two broad categories of arteriovenous shunts can be recognized: AVMs and arteriovenous fistulae (AVFs). AVMs are characterized by a network of abnormal channels (nidi) between the arterial feeders and the draining veins. AVFs, in contrast, consist of a direct communication or opening between a feeding artery and a draining vein. AVMs and AVFs are the two basic forms of arteriovenous shunts that can be found throughout the central nervous system.

AVMs of both the brain and the spinal cord are not common diseases. Spinal cord AVMs (SCAVMs) in particular are still underdiagnosed entities that can give rise to acute-subacute spinal cord symptoms or progressive myelopathy. Clinical signs and symptoms vary, depending on the location and angioarchitecture of the lesion.

A complete clinical evaluation combined with imaging information are necessary for making the correct therapeutic decision. The primary diagnostic modality is currently magnetic resonance imaging (MRI), which is excellent in topographically localizing lesions. Digital subtraction angiography (DSA) gives important complementary information regarding the angioarchitecture and hemodynamics of lesions, which is crucial in treatment planning. The aim of treatment should be a significant improvement over the natural history of the disease, in comparison with the risks of therapy.

In the past, most AVMs were diagnosed during clinically recognized episodes. The access to imaging facilities has allowed their preclinical diagnosis. Follow-up of this incidentally discovered population of patients with AVMs suggests that the clinical course is more benign than previously believed. The classic postulate that AVMs are congenital malformations, hence implying their presence at birth, has not been supported by antenatal or pediatric imaging. On the contrary, it is likely that lesions found in young adults, although probably resulting from an early in utero “event,” are not present at birth. Pediatric cases or even neonatal series represent only a small portion of the cases and pertain to specific disease groups (hereditary hemorrhagic telangiectasia [HHT], vein of Galen malformations, pial AVFs).1

The purpose of this chapter is to give an overview of the classifications, angioarchitectures, clinical manifestations, and natural history of these diseases, with a brief review of the diagnostic and therapeutic approaches.

BRAIN ARTERIOVENOUS MALFORMATION

Incidence

The prevalence of brain AVMs (BAVMs) in a given population is difficult to estimate. It is believed that between 0.14% and 0.8% of the population may present with a BAVM in a given year.2,3 The variation in statistics results from studies of disparate populations, ranging from the residents in a small community4 to subjects of autopsy series.3 As previously alluded to, these numbers represent data collected before the era of noninvasive high-quality imaging modalities.

Classification and Angioarchitecture

There are two broad categories of arteriovenous shunts: malformations (AVMs) and fistulae (AVFs). AVMs may be small (micro-AVMs) with one or more “normal”-sized arteries, one or more draining veins, and a nidus smaller than 1 cm in diameter. Macro-AVMs, in contrast, have arteries and veins that are larger than normal; the size of the nidus is larger than 1 cm in diameter. Compartments can be observed within lesions either during angiography or at surgery. Each compartment may have a single or multiple arterial feeders. There may be single or multiple draining veins (Fig. 44-1).

Similarly, AVFs may be of the micro or macro type. AVFs are more frequent in children and are rare in adults (Fig. 44-2).

The architecture of an AVM is specific to the lesion. However, the chronicity of the shunt and the shear stresses on the remaining vasculature create nonmalformative secondary changes called high-flow angiopathy. These may by themselves create additional symptoms; under certain circumstances, they may also regress if the AVM is treated even partially.

Topography

The topography of a BAVM is best assessed by combining both MRI and angiographic information. Lesions in most locations recruit predictable arterial feeders and specific draining veins (Table 44-1). The primary defect is at the capillary level. In contrast to aneurysms (arterial defective) or cavernomas (venous defective), in which associated arterial and venous anomalies are seen, respectively, the arterial tree from where the AVM feeders originate and the venous system that drains the AVM have a classic anatomical disposition.

image

TABLE 44-1 Topography of Intracranial Arteriovenous Lesions and Vascular Territories

Rights were not granted to include this table in electronic media. Please refer to the printed book.

From Berenstein A, Lasjaunias P, Ter Brugge KG: Surgical Neurorangiography, vol 2.2: Clinical and Endovascular Treatment Aspects in Adults, 2nd ed., Berlin: Springer-Verlag, 2004.

Several general types of lesions can be differentiated on the basis of location. Of note, however, is that both macro- and micro-AVFs are encountered mostly on the surface of the brain. All so-called BAVMs are subpial in location with regard to the meningeal spaces. Vein of Galen aneurysmal malformation and adult choroidal AVMs are separate groups located outside the subpial space.

Lesions at the cortex

Arteriovenous lesions exclusively involving the cortex are exclusively fed by cortical arteries and drain into superficial veins. These lesions represent sulcal AVMs, as described by Valavanis and Yasargil.5

Cortical-subcortical lesions recruit cortical arteries and drain into superficial veins but may also drain into the deep venous system if the transcerebral venous system is patent. These represent the gyral type of AVMs described by Valavanis and Yasargil.5

In both cortical and cortical-subcortical lesions, some regions of the cortex drain to deeply located veins that should not be considered as truly part of the “deep venous system.” Such vessels include the medial veins of the temporal lobe and the basal vein of Rosenthal, the veins of the cerebellar vermis, and the precentral cerebellar veins.

Corticoventricular arteriovenous lesions correspond to the classic pyramid-shaped malformation, reaching the ventricular wall at their apex. Feeding arteries are both perforating and cortical. Draining veins are also deeply and superficially located.

Corticocallosal lesions belong to the corticoventricular group, inasmuch as they have the same venous characteristics, but they do not recruit “basal perforating” arteries. They drain into the subependymal veins and, later, into the deep venous system. The arterial supply to the corpus callosum is linked to the cortical arterial network (even though it may simulate perforating arterial channels in the supraoptic region) and to choroidal arteries at the splenium.

Multiple Brain Arteriovenous Malformations

Multiple BAVMs are rare. In this heterogeneous group of multifocal BAVMs, three types of patients can be distinguished: (1) those with HHT, also known as Rendu-Osler-Weber disease; (2) those with cerebrofacial arteriovenous metameric syndrome (CAMSs); and (3) those with unclassified multiple lesions. This distinction refers to the timing of the insult that created the malformations, later to be revealed morphologically or clinically (e.g., germinal, somatic-segmental).

Hereditary hemorrhagic telangiectasia

HHT is an autosomal dominant disorder characterized by a multisystemic vascular dysplasia and recurrent hemorrhage.6 Two gene mutations have been identified: on chromosome 9 (affecting production of endoglin; this form is known as type 1)7 and on chromosome 12 (affecting production of activin receptor-like kinase; this form is known as type 2). An uncharacterized third mutation is also suspected. These mutations lead to the formation of abnormal vessels and abnormal connections between vessels. It has to be emphasized that the target of dysfunction in HHT is not in arteries but in venules.

In the general population of patients with BAVMs, up to 2.2% of cases may be associated with HHT.8 With multiple BAVMs, however, up to 25% of cases are associated with HHT.9 Ten percent to 20% of HHT patients have cerebral involvement.10 In these patients, the cerebral vascular malformations manifest in three main phenotypes: large AVFs, small AVMs with a nidal diameter between 1 and 3 cm, and micro-AVMs with a nidal diameter smaller than 1 cm. These AVMs are often multiple and are almost exclusively located near the cortex.8,11 Although characteristic telangiectasia occur in the skin, oral mucosa, and the lips of patients with HHT, telangiectasia is not known to develop in the brain. High-flow type AVFs with venous ectasias are seen in children younger than 5 to 6 years of age; nidus-type lesions both large and small are seen in older children and in adults.1,1214 Twenty-five percent of single AVFs in children and 50% of multifocal AVFs occur in patients with HHT.

Cerebral DSA may demonstrate multiple areas of arteriovenous shunting, always cortical in location, either supratentorial or infratentorial. In addition, high-quality cerebral DSA can demonstrate tiny lesions, particularly micro-AVMs, which may appear occult on MRI, because these lesions usually have normal-sized feeding arteries and draining veins.10

However, patients with HHT who present with systemic complaints are more likely to develop acute neurological symptoms from embolic phenomena related to underlying pulmonary AVFs (recurrent brain abscesses, embolic stroke) than to the presence of a BAVM per se.

Cerebrofacial arteriovenous metameric syndromes

CAMSs,15 also called Wyburn-Mason or Bonnet-Dechaume-Blanc syndrome, are associated with ipsilateral AVMs of the brain, retina, and facial regions. Their segmental expression reflects their common origin from tissues involved in cerebrofacial vasculogenesis and angiogenesis. The metameric pattern of involvement is suggestive of a disorder of the neural crest or adjacent cephalic mesoderm15 at early segmental stages of differentiation.

False Arteriovenous Malformations

Proliferative and hemorrhagic angiopathies

Proliferative and hemorrhagic angiopathies are entities often confused with BAVMs. They are rare, proliferative, vascular lesions seen usually in children and young women.

The appearance of proliferative angiopathy is typically that of a nidus-like cortical network of vessels intermingled with normal brain parenchyma, and the veins are either normal sized or only slightly enlarged. The “nidus” is typically diffuse, involving a hemisphere. There are no dominant arterial feeders. The early venous filling that is observed results from a faster capillary transit time rather than true arteriovenous shunting. Late proximal cerebral arterial occlusion may occur, resulting in ischemic phenomena and diffuse transdural angiogenesis. The most common clinical manifestation is seizures. Headaches and progressive neurological deficit are less common, and hemorrhage is exceptional. Treatment is directed at the management of seizures with medical therapy. Embolization is employed in exceptional cases: when there is evidence of focal angioarchitectural weakness within the lesion, for which partial targeted embolization to reduce any constraints to functional parts of the brain may be beneficial. The effects of medication on headaches and seizure are often beneficial. The role of surgery is limited to the correction of hemispherical ischemia by bur holes, as in moyamoya disease, when spontaneous transdural angiogenesis is absent or insufficient.

Hemorrhagic angiopathy is another entity that typically manifests with an episode of hemorrhage. Encountered in some rare cases of intracerebral hematomas in children most often after the age of 5 years, it corresponds to a network of intracerebral subcortical arterioles with normal structure and sequential venous drainage. Recurrent hemorrhage is frequent and therefore therapy is indicated. These lesions are extremely sensitive to radiation. Partial embolization of focal areas of weakness in the angioarchitecture can also be performed to reduce future hemorrhagic risk.

Pathophysiology, Clinical Manifestation, and Natural History

The clinical manifestation of BAVM may be related to the shunt itself or to secondary changes (visible on high-flow angiopathy) that occur in response to chronic shunting. It also depends on the age of the patient. Manifesting clinical features include chronic headaches, seizures, cerebral hemorrhage, and neurological deficits.

Hemorrhage

Hemorrhage in a patient with a BAVM represents a significant change in the compliance of the vascular system. Bleeding can result from rupture of the AVM nidus, arterial aneurysm rupture, or venous rupture, which may occur close to or remote from the AVM. It has been shown that arterial aneurysms are not significantly associated with hemorrhagic manifestation,5 of BAVMs. The presence of aneurysms within an AVM nidus is, however, noted to significantly worsen the natural history of future hemorrhages.16 Deep venous drainage and deep location of a BAVM are associated with a higher risk of hemorrhagic manifestation.17